SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934 (Amendment No. )*
Healthcare Imaging Services, Inc.
(Name of Issuer)
Common Stock, par value $.01 per share
(Title of Class of Securities)
421939109
(CUSIP Number)
Ulises C. Sabato, M.D. With a copy to:
106 Grand Avenue Laura R. Kuntz, Esq.
Englewood, NJ 07631 Lowenstein, Sandler, Kohl,
(201) 894-8242 Fisher & Boylan, P.A.
65 Livingston Avenue
Roseland, New Jersey 07068
(973) 992-8700
(Name, Address and Telephone Number
of Person Authorized to Receive
Notices and Communications)
May 21, 1996
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule l3G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box |_|.
Note: Six copies of this statement, including all exhibits, should be filed
with the Commission. See Rule l3d-1(a) for other parties to whom copies are to
be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
CUSIP No. 421939109
- --------------------------------------------------------------------------------
(1) Names of Reporting Persons S.S. or I.R.S. Identification Nos. of Above
Persons:
Ulises C. Sabato, M.D.
- --------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member of a Group (See Instructions):
(a) [ ] (b) [ ]
- --------------------------------------------------------------------------------
(3) SEC Use Only
- --------------------------------------------------------------------------------
(4) Source of Funds (See Instructions): PF, 00
- --------------------------------------------------------------------------------
(5) Check Box if Disclosure of Legal Proceedings is Required Pursuant
to Items 2(d) or 2(e): [ ]
- --------------------------------------------------------------------------------
(6) Citizenship or Place of Organization: United States
- --------------------------------------------------------------------------------
Number of Shares (7) Sole Voting Power: 732,365*
Beneficially Owned (8) Shared Voting Power: 0
by Each Reporting (9) Sole Dispositive Power: 732,365*
Person With: (10) Shared Dispositive Power: 0
- --------------------------------------------------------------------------------
(11) Aggregate Amount Beneficially Owned by Each Reporting Person: 732,365
- --------------------------------------------------------------------------------
(12) Check if the Aggregate Amount in Row (11) Excludes
Certain Shares (See Instructions): [ ]
- --------------------------------------------------------------------------------
(13) Percent of Class Represented by Amount in Row (11): 8.2%
- --------------------------------------------------------------------------------
(14) Type of Reporting Person (See Instructions): IN
- --------------------------------------------------------------------------------
*Includes 147,000 shares held in a pension plan for the benefit of Dr. Sabato
and 50,000 shares issuable upon the exercise of options that are presently
exercisable by Dr. Sabato.
<PAGE>
Item 1. Security and Issuer.
This Schedule 13D of Dr. Ulises C. Sabato relates to the Common Stock,
par value $.01 per share (the "Common Stock"), of Healthcare Imaging Services,
Inc. (the "Company"). The principal executive offices of the Company are located
at 200 Schulz Drive, Red Bank, NJ 07701.
Item 2. Identity and Background.
The person filing this statement is Dr. Ulises C. Sabato, whose
business address is 106 Grand Avenue, Englewood, New 07631. Dr. Sabato is a
neurologist in private practice.
Dr. Sabato has never been convicted in any criminal proceeding, nor
has he been a party to any civil proceeding commenced before a judicial or
administrative body of competent jurisdiction as a result of which he was or is
now subject to a judgment, decree or final order enjoining future violations of,
or prohibiting or mandating activities subject to, federal or state securities
laws or finding any violation with respect to such laws.
Dr. Sabato is a citizen of the United States.
Item 3. Source and Amount of Funds or Other Consideration.
All funds used to purchase shares of Common Stock on behalf of Dr.
Sabato have come directly from Dr. Sabato's personal funds. In addition to his
purchases, Dr. Sabato received a total of 127,365 shares of Common Stock in
June, 1994 in consideration for the sale of a MRI center which he previously
owned.
Item 4. Purpose of the Transaction.
The acquisition of the shares of Common Stock referred to in Item 5 is
solely for investment purposes on behalf of Dr. Sabato. Dr. Sabato has no
present plans or intentions which relate to or would result in any of the
transactions required to be described in Item 4 of Schedule 13D.
Item 5. Interest in Securities of the Issuer.
Based upon the information set forth in the Company's Quarterly Report
on Form 10-Q for the period ended September 30, 1997, as of November 11, 1997
there were 8,856,474 shares of Common Stock issued and outstanding. As of
December 1, 1997, Dr. Sabato beneficially owned an aggregate of 732,365 shares
(including 147,000 shares held in his pension plan and 50,000 shares issuable
upon the exercise of stock options which are currently exercisable) or 8.2% of
the outstanding shares. Dr. Sabato possesses sole power to vote and to direct
the disposition of all shares of Common Stock beneficially owned by him. The
only transaction effected by Dr. Sabato in the Company's Common Stock during the
60 days prior to December 1, 1997 was a purchase of 50,000 shares on November
20, 1997 at a price of $1-1/16 per share. This purchase was effected in an
ordinary broker's transaction.
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect
to Securities of the Issuer.
No contracts, arrangements, understanding or similar relationships
exist with respect to the shares of Common Stock of the Company between Dr.
Sabato and any person or entity.
Item 7. Materials to be Filed as Exhibits.
Not Applicable.
Signature
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: December 10, 1997
/s/Ulises C. Sabato, M.D.
------------------------------
Ulises C. Sabato, M.D.
ATTENTION: INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACT CONSTITUTE FEDERAL
CRIMINAL VIOLATIONS (SEE 18 U.S.C. 1001).
